Method for modifying the surface properties of elastomeric cellular foams
By chemically modifying the surface of the honeycomb polymer foam, using catechol unit compounds and catalytically active materials, the problems of high cost and limited mechanical properties of ceramic foam are solved, and the preparation of low-cost catalyst matrix and simple recovery of active phases are achieved.
Patent Information
- Application Number
- CN201580039797.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2014-07-22
- Filing Date
- 2015-07-09
- Publication Date
- 2024-12-03
- Estimated Expiration
- 2035-07-09
AI Technical Summary
The existing ceramic foams are costly and have limited mechanical properties when used in high-thermal strength environments, and the recovery of the active metal phase requires complex chemical treatment, making it difficult to use as a low-cost catalyst matrix.
By chemically modifying the surface of the cellular polymer foam, contacting the cellular polymer foam using catechol unit compounds such as dopamine to form an intermediate phase and by deposition of catalytically active materials or nanoparticles, the adhesion of the foam is enhanced for use in catalysts Base body.
The catalyst matrix with low pressure loss and high specific surface area is achieved at low cost, with mechanical flexibility and extensive geometric adaptability, simplifying the deposition and recovery process of the active phase.
Smart Images

Figure BDA0001211454810000121 
Figure BDA0001211454810000141 
Figure BDA0001211454810000142
Abstract
Description
Technical Field
[0001] The present invention relates to the field of porous solid materials, more particularly cellular polymer foams. It relates to a method for modifying the surface of elastomeric cellular foams, particularly foams having a pronounced porosity, so that they can be used as catalyst substrates. Background Art
[0002] Many catalysts are known in which the catalytic phase is present in a porous solid material and more specifically adsorbed to the surface of a ceramic or metal honeycomb foam. For example, the most widely used method for producing ceramic foams consists of impregnating a polymer foam cut into a desired geometry, typically a polyurethane or polyester foam, with a suspension of ceramic particles in an aqueous or organic solvent. Excess suspension is discharged from the polymer foam by repeated application of compression or by centrifugation so that only a fine particle layer of the suspension remains on the strands of the polymer. After one or several impregnations of the polymer foam, the latter is dried so as to empty the solvent while retaining the mechanical integrity of the deposited layer of ceramic powder. The foam is then sintered to obtain an inorganic foam that can be used as a catalyst matrix. This extremely complex manufacturing method results in relatively high manufacturing costs.
[0003] One advantage of ceramic foams is their chemical and thermal strength. However, excellent thermal strength is not always required. In addition, ceramic foams have the disadvantage of hiding microcracks and other microstructural defects that significantly reduce their mechanical properties. In addition, in many cases, recovery of the active metal phase (catalyst) requires a lot of chemical treatment.
[0004] An object of the present invention is to provide a novel catalyst substrate that is an alternative to catalyst substrates made of metal or ceramic foams currently used in the chemical, pharmaceutical and / or cosmetic industries in environments that do not require high thermal intensity; is easy to prepare at low manufacturing costs; and has similar or advantageous structural characteristics.
[0005] Another object of the present invention is to provide novel catalysts for heterogeneous and / or supported homogeneous catalysis, which have low pressure losses and have a large specific surface area while having very good chemical inertness and which can have all types of geometries (square, planar, cylindrical, etc.) and mechanical flexibility. Summary of the invention
[0006] According to the invention, the problem is solved by chemically modifying the surface of a known cellular material, ie a cellular polymer foam (in particular an elastomer) having a significant porosity.
[0007] Cellular polymer foams (also called "honeycomb foams") are well known and commercially available for many applications. When they consist of closed cells, they have excellent mechanical strength and are used as foam wedges, packaging foams or in machine construction. At the same time, these closed cells trap air and thus give the foam excellent thermal insulation properties for use in the construction industry.
[0008] Also known are polymer foams (in particular elastomers) with a pronounced porosity (referred to as "open-cell polymer foams"), in which only the edges of the pores consist of solid polymer. This relates in particular to polyurethane foams. They are used as filters, in particular in aquariums. However, due to the low adhesion of the catalyst (or its precursor compound) to the surface of this polymer, these foams cannot be used as catalyst substrates.
[0009] Its use as a catalyst matrix faces difficulties in depositing catalytically active phases or active phase precursors. In fact, the surface of the polymer bridges (edges) is smooth, without micropores, and does not have sufficient adhesion to deposit precursor molecules or active phases commonly used for homogeneous or heterogeneous catalysis on it. For this reason, honeycomb polymers with significant porosity have been difficult to be considered as candidates for making catalyst matrices.
[0010] The present inventors have discovered appropriate surface treatments to prepare cellular polymer foams (particularly elastomers), and particularly those having significant porosity, to receive deposition of a catalytically active phase (referred to herein as "active phase") or active phase precursor phase.
[0011] A first object of the present invention is a method for modifying a cellular polymer foam having a pronounced porosity, preferably made of polyurethane, comprising the following steps:
[0012] a) supplying a porous cellular polymer foam (a) having a significant porosity;
[0013] b) placing said cellular polymer foam in contact with at least one compound (b) chosen from compounds comprising at least one catechol unit, and preferably chosen from catecholamines, to obtain a cellular polymer foam comprising, on its surface, a mesophase formed by said compound comprising at least one catechol unit.
[0014] The cellular polymer foam is advantageously a polyurethane foam.
[0015] In one embodiment, the step of placing the cellular polymer foam (a) and the compound (b) in contact is accomplished by immersing the cellular polymer foam (a) in an aqueous solution of the compound (b), or by impregnating the aqueous solution of the compound (b) on the cellular polymer foam (a), or by partially or completely spraying the aqueous solution of the compound (b) on the cellular polymer foam (a).
[0016] Advantageously, said cellular polymer foam (a) comprises pores having an average size comprised between 500 and 5000 μm, preferably between 2000 and 4500 μm and even more preferably between 2500 and 4500 μm; these values are chosen in order to use the foam as catalyst matrix.
[0017] Compound (b) preferably comprises one (preferably only one) amine function and is advantageously chosen from catecholamines, and more particularly 4-(2-aminoethyl)benzene-1,2-diol (known as dopamine), or a derivative thereof. As an example, compound (b) may be chosen from the group consisting of dopamine, norepinephrine, epinephrine, 3-methoxytyramine, 4-aminophenol, 3,4-dihydroxyphenyl-L-alanine.
[0018] If compound (b) is not an amine, it is preferably selected from the group of compounds comprising at least one catechol unit formed by: caffeic acid, hydroxyhydroquinone, catechol, pyrogallol, morin (2',3,4',5'7-pentahydroxyflavone), epigallocatechin, epigallocatechin gallate, catechin and its stereoisomers, tannic acid.
[0019] The method according to the invention may further comprise a step c) for functionalizing the cellular polymer foam by depositing a phase of at least one catalytically active material or a precursor of a catalytically active phase, said at least one material (c) being chosen from the group consisting of:
[0020] - a metal complex comprising at least one group capable of forming a covalent bond with the coating formed by compound (b), i.e. having a catechol or indole structural unit (resulting from the cyclization of the alkylamine arms of the catecholamine during step (b)), such as a trialkoxysilyl group, an amine group or a thiol group, and more particularly a coordination compound of a transition metal or an organometallic molecule;
[0021] - organic molecules capable of catalyzing reactions, called organocatalysts, comprising at least one group capable of forming a covalent bond with the coating formed by compound (b);
[0022] - Metal nanoparticles, preferably chosen from metal nanoparticles of Ag, Fe, Co, Ni, Ru, Rh, Pd, Ir, Pt, Au, Ce or those of mixed oxides associated with these elements, such as Fe2O3, NiO2, Ni2O3, CeO2 and those chosen from other oxides, such as TiO2, ZnO, WO3, SnO2 or any possible combination of these nanoparticles.
[0023] This functionalization step can be carried out after or simultaneously with the deposition of compound (b).
[0024] According to one embodiment, the functionalization step is carried out at a temperature comprised between 5 and 80°C, preferably between 15 and 60°C, and even more preferably between 15 and 50°C.
[0025] The metal nanoparticles have an average particle size comprised between 0.5 nm and 30 nm, preferably between 0.5 nm and 30 nm, more preferably between 0.5 nm and 20 nm, and even more preferably between 0.5 nm and 15 nm.
[0026] The catalytically active phase or catalytically active phase precursor may be deposited using at least one of the following techniques:
[0027] - Immersion, aerosol or droplet;
[0028] - Chemical vapor deposition;
[0029] - Capillary impregnation.
[0030] This step can be performed after or simultaneously with the deposition of compound (b).
[0031] The cellular foam implemented in the context of the present invention takes the form of a block (e.g., cylindrical or cubic) or a plate having any shape, but the smallest external dimension must be significantly larger than the average size of the cells, and is generally at least three times, preferably at least five times, of this value. In general, the smallest dimension is greater than about 3 mm, preferably greater than about 10 mm, and even more preferably greater than about 20 mm.
[0032] Another object of the present invention is a functionalized cellular polymer foam having a pronounced porosity, which is obtainable using the process according to the invention.
[0033] A further object of the present invention is the use of a cellular polymer foam with pronounced porosity, obtainable using the process according to the invention, as a catalyst substrate.
[0034] A further object of the present invention is the use of the functionalized cellular polymer foam with pronounced porosity, obtainable using the process according to the invention, as catalyst, and more particularly as supported homogeneous and / or heterogeneous catalyst. BRIEF DESCRIPTION OF THE DRAWINGS
[0035] Figures 1 to 8 The present invention will be described.
[0036] Figure 1 (a) shows a micrograph obtained by optical microscopy of a polyurethane honeycomb foam having significant porosity for use in the process according to the present invention, wherein the cell size is about 4.433±0.362 mm; the window size is about 2.423±0.341 mm; and the bridge diameter is about 0.460±0.047 mm. The length of the white bar in the upper right indicates 5 mm.
[0037] Figure 1 (b) shows a micrograph obtained by optical microscopy of a polyurethane cellular foam with pronounced porosity used in the process according to the invention, identifying the characteristic properties of the foam (cell size "Φ", pore size (i.e., window size) "a", and bridge size "d s ”).
[0038] Figure 2a Shown O 1s / C 1s The atomic ratios were obtained by X-ray photoelectron spectroscopy. C31410Bulpren TM The results were measured on the surface of polyurethane elastomer cellular foams of the type 1000, unmodified and under several conditions of the method according to the invention (control C31410 polyurethane foam: Figure 1000; after placing in contact with compound (b) and after a single wash = bar A; after two washes = bar B; after three washes = bar C). An increase in the ratio of oxygen atoms between the control C31410 foam and the foam modified by compound (b) was observed, with reference to the adhesion of polydopamine (referred to herein as PDA), a polymerization product of compound (b). After 1, 2 or 3 consecutive washes, the ratio of oxygen atoms increased. 1s / C 1s The ratio remained unchanged, reflecting the robustness of the modification.
[0039] Figure 2b Shown O 1s / C 1s The atomic ratios were obtained by X-ray photoelectron spectroscopy. The results are shown in Figure 1, which are measured on the surface of a polyurethane elastomer cellular foam of the 8FM2 type, unmodified and under several conditions of the process according to the invention (control 8FM2 polyurethane foam: Figure 1; after placing in contact with compound (b) and a single wash = bar A; after two washes = bar B; after three washes = bar C). The increase in the ratio of oxygen atoms relative to carbon atoms between the 8FM2 control foam and the foam modified by compound (b) demonstrates the grafting of PDA (compound (b)). This grafting is measured according to the O measured after 1, 2 or 3 washing steps. 1s / C 1s The ratios are not robust to change; cf. bars A, B and C, respectively.
[0040] Figure 3a , Figure 3b and Figure 3c Micrographs obtained by scanning electron microscopy (SEM) of a polyurethane elastomer cellular foam are shown at different stages of the process according to the invention.
[0041] Figure 3a for C31410Bulpren TM Micrograph of an unmodified polyurethane foam of type 1. The length of the white bar at the bottom right indicates 10 μm.
[0042] Figure 3b After being placed in contact with an aqueous dopamine solution, also known as 4-(2-aminoethyl)benzene-1,2-diol (CAS: 51-61-6), Figure 3a Micrograph of a polyurethane foam shown in . The length of the white bar at the bottom right indicates 10 μm.
[0043] Figure 3c For Figure 3b Micrograph of a polyurethane foam after the foam obtained in was placed in contact with an aqueous solution of TiO2 nanoparticles. The length of the white bar at the bottom right indicates 1 μm.
[0044] Figure 4 Shown is the evolution of the absorption spectrum of Acid Orange 7 (AO7 or sodium 4-[(2E)-2-(2-oxonaphthalen-1-ylidene-hydrazino]benzenesulfonate; CAS: 633-96-5) in the presence or absence of TiO2 nanoparticles and at t=0 and t=22 hours and during a second catalytic cycle with the same reused polyurethane foam at t=22 hours.
[0045] Figure 5a and Figure 5b The uncontacted polyurethane elastomer honeycomb foam ( Figure 5a ) and using the method according to the invention by dopamine deposition ( Figure 5b ) Micrograph obtained by SEM (accelerating voltage 3.0 kV) of functionalized . The length of the white bar in the upper right indicates 100 μm.
[0046] Figure 6a and Figure 6b Shown is a micrograph obtained by SEM (accelerating voltage 15.0 kV) of a polyurethane elastomer honeycomb foam after functionalization with dopamine and deposition of TiO2 nanopowder. The length of the white bar in the upper right indicates 1 μm. In each figure, the dark rectangle indicates the area where the chemical composition has been analyzed by EDX spectroscopy (x-ray emission caused by the electron beam of the SEM device): Figure 6a shows the characteristic emission lines of elements C, O and Ti, while Figure 6b Only the emission lines of elements O and C are shown.
[0047] Figure 7 and Figure 8 Concerning experiments carried out with a catalytic foam prepared according to Example 8. Figure 8 Stress-strain curves are shown for a new sample (curve 1) and after 5,000 compression cycles at 25% (curve 2).
[0048] Figure 7 Photocatalytic performance tests related to the catalytic foam prepared according to Example 8. It corresponds to conversion tests as a function of time of polyurethane elastomer cellular foam after functionalization with dopamine and deposition of TiO2 nanopowder, new (curve 1) and after 5,000 compression cycles at 25% (curve 2). DETAILED DESCRIPTION
[0049] The cellular (also called "honeycomb") polymer foams (and in particular elastomers) used in the context of the method according to the invention are so-called solid foams with a pronounced porosity. Preferably, these are polyurethane foams. The latter are commercially available in large tonnages and at low cost. They are flexible and particularly resistant to mechanical and chemical stresses, while having morphological properties that allow intimate mixing of the reagents and therefore the ability to achieve chemical conversions under gentle conditions (mainly in terms of temperature and pressure) compared to systems in which the catalyst is deposited on a substrate of known type that does not assume the form of an open-cell foam.
[0050] Honeycomb or cellular foams with pronounced porosity take the form of a structure consisting of interconnected pores randomly distributed throughout the structure of the material. In a first approximation, cellular foams have a regular pentagonal dodecahedron-type geometry and are classified based on their characteristic size ( Figure 1 b):
[0051] - "Φ": average size of the pores, corresponding to the average equivalent diameter of a sphere that fits in the pores;
[0052] - "a": average equivalent diameter of the opening of the pores, also called the size of the "window" or the size of the "pore";
[0053] -"d s ”: The average equivalent diameter of the bridge, also known as the characteristic length of the solid skeleton, is the size of the “bridge” here.
[0054] In the trade, these foams are classified based on the number of pores (windows) per unit length: PPI (pores per inch).
[0055] In another embodiment of the invention, the modified open-cell foam according to the invention has a substrate of a synthetic organic foam. This means that the foam according to the invention is made of an open-cell foam comprising a synthetic organic material, preferably a polyurethane foam. The preparation of polyurethane cellular foams is well known to those skilled in the art. Typically, such foams can be obtained by a polymerization reaction between an isocyanate and an alcohol.
[0056] The method for modifying the honeycomb (or honeycomb) polymer foam (in particular, elastomer) according to the present invention is a method for modifying its surface. It comprises (preferably, essentially comprises) the following two steps:
[0057] a) in a first step, providing a cellular polymer foam (a) having a significant porosity, preferably a polyurethane elastomer cellular foam,
[0058] b) In a second step, the cellular polymer foam is placed in contact with at least one compound (b) chosen from compounds comprising at least one catechol unit, and preferably chosen from catecholamines.
[0059] Advantageously, the foam comprises pores having a mean size Φ comprised between 500 μm and 5,000 μm, preferably between 2,000 μm and 4,500 μm and even more preferably between 2,500 μm and 4,500 μm.
[0060] Advantageously, the average equivalent diameter a of the openings of the pores (windows) of the cellular polymer foam is comprised between 100 μm and 5,000 μm, preferably between 800 μm and 3,000 μm. In another embodiment, this parameter is between 1,700 μm and 4,500 μm.
[0061] Advantageously, the average equivalent diameter d of the bridges of the cellular polymer foam is s It is comprised between 50 μm and 3,000 μm, preferably between 80 μm and 2,500 μm. In another embodiment, this parameter lies between 200 μm and 2,500 μm.
[0062] Advantageously, the PPI amount will be comprised between 5 PPI and 100 PPI, preferably between 30 PPI and 75 PPI.
[0063] In a first advantageous embodiment, the average pore size Φ is between 2,000 μm and 4,500 μm, the average window size a is between 800 μm and 3,000 μm, and the average bridge diameter d s Between 80 μm and 2,000 μm.
[0064] In a second advantageous embodiment, the average pore size Φ is between 2,500 μm and 4,500 μm, the average window size a is between 1,000 μm and 3,000 μm, and the average bridge diameter d s Between 100 μm and 1,500 μm.
[0065] In a third advantageous embodiment, the average pore size Φ is between 3,000 μm and 5,000 μm, the average window size a is between 1,300 μm and 3,500 μm, and the average bridge diameter d s Between 130μm and 1,750μm.
[0066] Here, "catecholamine" refers to a compound comprising a catechol nucleus (1,2-dihydroxybenzene), which further comprises alkylamine (optionally substituted) side chains. Components comprising a single amine functional group are preferred to those comprising several amines or polyamines (or components in which the catechol unit reacts with two amines), which should be avoided. According to the present invention, the compound selected from the catecholamines (which are preferably catechol monoamines) is advantageously dopamine [4-(2-aminoethyl)benzene-1,2-diol (CAS: 51-61-6)], or a derivative thereof. Other compounds with catechol units and amine functional groups that can be used are, for example, noradrenaline, epinephrine and 3,4-dihydroxyphenyl-L-alanine. However, other molecules that simply carry catechol units can lead to similar modifications of the surface of the honeycomb polymer foam.
[0067] Thus, as an example, compound (b) can be selected from the group formed by: dopamine, norepinephrine, epinephrine, 3-methoxytyramine, 4-aminophenol, caffeic acid, hydroxyhydroquinone, catechol, pyrogallol, morin (2',3,4',5'7-pentahydroxyflavone), epigallocatechin, epigallocatechin gallate, catechin and its stereoisomers, tannic acid, and 3,4-dihydroxyphenyl-L-alanine.
[0068] Although the chemical nature of polydopamine (and fortiori, which is the polymerization product of other useful molecules as indicated above) has not yet been clearly established, the inventors believe that the primary amine functions present in the catecholamines play an important role in initiating the polymerization process: under oxidative conditions, dopamine is converted into an aromatic ring of the indole type which is then the actual polymerization monomer: the amine present in this indole derivative is a secondary amine.
[0069] Thus, the polymerization process according to the invention results in an at least partially polymerized coating (mesophase) with little or no free primary amines; this is important to allow its use in catalysis. Indeed, amine or ammonium surface groups are not favorable for binding to metal or oxidic nanoparticles. Preferred groups are of the sulfonate, alcohol or alcoholate, carboxylic acid or carboxyl, phenyl or phenolate type. Furthermore, the inventors have found that the presence of free amine groups does not allow the functionalization of the foam of the mesophase according to the invention including other molecules of the amine or sulphur derivative type, to have further freedom in the modification of its surface for various catalytic applications.
[0070] For these reasons, in the context of the present invention, compounds of the catecholamine type are preferred to compounds comprising a catechol unit without a nitrogen function.
[0071] In one embodiment of the method according to the invention, at least one compound having at least one catechol unit, and preferably a compound in the catecholamine family, and even more preferably dopamine or 4-(2-aminoethyl)benzene-1,2-diol is supplied in an aqueous solution, wherein the amount is comprised between 0.05% by weight and 10% by weight, preferably between 0.1% by weight and 1% by weight. The step for placing the elastomeric cellular foam (a) and the compound (b) in contact can be carried out via several methods. As an example, the contact can be carried out by immersing the elastomeric cellular foam (a) in an aqueous solution of the compound (b); impregnating the aqueous solution of the compound (b) on the elastomeric cellular foam (a); or partially or completely spraying the aqueous solution of the compound (b) on the elastomeric cellular foam (a).
[0072] Advantageously, the placing in contact of the cellular polymer foam and the aqueous solution of compound (b), in particular by immersion, dipping or spraying, is carried out for a period comprised between 1 hour and 48 hours, preferably between 18 hours and 36 hours, even more preferably between 20 hours and 30 hours.
[0073] Advantageously, the contacting of the cellular polymer foam (a) and the compound (b) is carried out at a temperature ranging from 0°C to 100°C, preferably from 15°C to 35°C, and particularly preferably from 20°C to 30°C.
[0074] In a particularly advantageous embodiment, the cellular polymer foam (a) is placed in contact with an aqueous solution of compound (b) at a pH comprised between 5 and 10, preferably between 8 and 9. The pH of the solution can be checked by using a buffer solution, for example a tris(hydroxymethyl)aminomethane hydrochloride buffer solution (Tris·HCl; CAS: 1185-53-1).
[0075] Advantageously, the placing of the cellular polyurethane foam (a) and the compound (b) in contact can be carried out in an aqueous solution or in a water-miscible organic aqueous / solvent mixture. The use of water as solvent is preferred.
[0076] Several channels for functionalizing cellular polymer foams with modified surfaces by the cellular polymer foam conversion method according to the invention are considered and tested, in particular for use as catalyst substrates. To this end, the method according to the invention comprises a further step c) for functionalizing the catalyst substrate by depositing at least one catalytically active material (c).
[0077] In one embodiment of the method for functionalizing a catalyst substrate according to the present invention, the functionalization of the substrate is carried out by grafting a catalyst in the form of a metal complex, specifically the metal complex comprising at least one group capable of forming a covalent bond with a coating formed by compound (b) (i.e., having a catechol or indole structural unit (resulting from the cyclization of the alkylamine arm of the catecholamine during step (b))); the group may, for example, be an alkoxysilyl group, a halosilyl group (such as a chlorosilyl group), an amine group or a thiol group, and the reaction carrying out the covalent bond formation may be, for example, a condensation reaction with the hydroxyl functional group of the catechol structural unit, a reaction leading to imine formation, a 1,4-type addition or a free radical type reaction.
[0078] Said grafting of metal complexes makes it possible to obtain supported homogeneous catalysts, also known as single-site heterogeneous catalysts. Advantageously, the metal complexes used in the context of the functionalization process according to the invention (comprising at least one group capable of forming a covalent bond with the catechol and / or indole structural unit) are chosen from organometallic molecules or coordination compounds, and more particularly from those comprising at least one transition metal.
[0079] In one embodiment of the method for functionalizing a catalyst substrate according to the invention, the functionalization of the substrate is carried out by grafting a catalyst in the form of an organic molecule (organic catalyst) comprising at least one group capable of forming a covalent bond with a coating formed by compound (b) (i.e., having a catechol or indole structural unit (resulting from the cyclization of the alkylamine arm of dopamine during step (b))); the group may, for example, be an alkoxysilyl group, a halosilyl group (such as a chlorosilyl group), an amine group or a thiol group, and the reaction carrying out the covalent bond formation may, for example, be a condensation reaction with the hydroxyl functional group of the catechol structural unit, a reaction achieving imine formation, a 1,4-type addition or a reaction of the free radical type.
[0080] The grafting of organic catalysts makes it possible to obtain supported organic catalysts.
[0081] In one embodiment of the method for functionalized catalyst substrate according to the present invention, the functionalization of substrate is carried out by non-covalent grafting with the catalyst in the form of metal particles, which are advantageously metal nanoparticles. Due to the presence of catechol groups, the grafting of metal particles on the surface of substrate is effective. Therefore, people have substrates for heterogeneous catalysts. Advantageously, the metal particles used for the content of functionalization method according to the present invention are selected from Ag, Fe, Co, Ni, Ru, Rh, Pd, Ir, Pt, Au, Ce or those of mixed oxides associated with these elements, such as Fe2O3, NiO2, Ni2O3, CeO2 and those selected from other oxides, such as TiO2, ZnO, WO3, SnO2 or all possible combinations of these nanoparticles. Advantageously, the metal nanoparticles used for the content of the method according to the present invention have an average particle size contained between 0.5nm and 100nm, preferably between 0.5nm and 20nm, and more preferably between 0.5nm and 15nm. The size of the catalytic nano-objects under consideration may depend on their composition, and specifically their metallic or oxidic nature: the surface properties are closely related to the size of metal nanoparticles (gold and ruthenium, for example), and to a lesser extent in the case of oxides (TiO2).
[0082] Preferably, the step for functionalizing the catalyst substrate is carried out by depositing the active phase using at least one of the following techniques:
[0083] - Immersion, aerosol or droplet;
[0084] - Chemical vapor deposition;
[0085] - Capillary impregnation.
[0086] This functionalization step can be carried out after or simultaneously with the deposition of compound (b).
[0087] Advantageously, the step for functionalizing the catalyst substrate is carried out at a temperature comprised between 5 and 80°C, preferably between 15 and 60°C and even more preferably between 15 and 50°C.
[0088] The present invention makes it possible to form a significant improvement relative to the heterogeneous catalyst loaded by hard honeycomb foam (for example, carbon foam, silicon carbide foam, metal foam or aluminum oxide foam). In fact, compared with commonly used metal or ceramic foam, polyurethane foam (which is an elastomer foam) has large flexibility and good impact resistance. In addition, the active phase of the honeycomb foam obtained using the method according to the present invention can be easily recovered, such as by the simple combustion of the honeycomb foam, which is an advantage that cannot be ignored, particularly when the material used as the active phase is very expensive. For metal or ceramic foam according to the state of the art, the recovery of the active phase requires complex and polluting chemical treatment.
[0089] A particular example of the catalytic matrix according to the invention relates to the choice of compound (b), which is chosen from compounds having at least one catechol unit, and preferably from catecholamines. In fact, the main drawback of polymer foams used as catalyst substrates is their resistance to low temperatures: it is not possible to subject active phase precursors (e.g. metal oxides) deposited on these substrates to the same activation treatments (generally: hydrogen production) as when they are deposited on metal or ceramic foams, since this reaction requires temperatures that risk destroying the polymer foam. This is one of the main reasons why cellular polymer foams, in which there is a pronounced porosity, have not been used as catalyst substrates (other reasons are the low adhesion of active phase precursors or active phases due to the smoothness of the surface forming the bridges of the cellular foam). The inventors have found that modifying the surface of the cellular polymer foam according to the invention with a compound having at least one catechol unit, and preferably chosen from catecholamines (such as dopamine), makes it possible to overcome both difficulties simultaneously. In particular, it is possible to remove the reduced phase of the active phase precursor deposited on the polymer foam, since the catecholamines act as reducing agents; this effect is more pronounced when the active phase precursor is deposited in the form of nanoparticles. Furthermore, the presence of a compound having at least one catechol unit, in particular a catecholamine, stabilizes the chemical integrity of the nanoparticles, in particular with respect to the oxidizing action of air, which could damage or inactivate the nanoparticles.
[0090] Furthermore, when the modified cellular polymer foams obtained according to the process of the invention can be used as supported homogeneous catalysts or as supported organic catalysts (which is not possible with metal or ceramic foams, which can only be used as heterogeneous metal catalyst substrates), the separation of product and catalyst is made significantly easier with respect to non-supported catalysts (in particular, for fine chemistry or for hydroformylation reactions), which allows the transition to industrial scale reactions in which it would not be possible to consider using them under homogeneous conditions, in particular due to the difficulties of separating homogeneous catalysts from reaction products. In fact, in certain areas of chemical processes, such as pharmaceutical chemical processes, the metal content remaining in the products obtained by catalysis (from the metal catalyst) must not exceed a threshold value set at a very low content.
[0091] Compared to conventional reactors (discontinuous, semi-continuous or closed reactors, known as "batch reactors"), the process according to the invention allows catalytic reactions under "mild" temperature and pressure conditions, due to the material transfer properties of the foam, in particular in the case of two-phase reactions (gas / liquid), such as in hydrogenation or hydroformylation reactions.
[0092] Therefore, the modified cellular foams obtained using the method according to the invention have many advantages over the hard metal or ceramic foams currently used as substrates in the chemical, pharmaceutical and / or cosmetic industries. In fact, hard metal or ceramic foams have a certain amount of limitations. In particular, they are not flexible: the metal or ceramic foams traditionally used are very easy to break. In addition, the choice of catalyst types that can be supported is limited to metal (nano) particles adsorbed on the surface, and are therefore only heterogeneous metal catalysts. In addition, the catalysts deposited on these known substrates are not very durable, and their aging is mainly due to desorption and oxidation of the metal species on the foam. And finally, hard metal or ceramic foams are extremely expensive.
[0093] The cellular polymer foam modified according to the invention by placing it in contact with at least one compound selected from the group consisting of catecholamines undergoes further chemical functionalization, for example the covalent grafting of compounds comprising silane groups, amine groups or thiol groups. This makes it possible to further broaden the spectrum of surface properties that can be imparted to the cellular polymer foam using the method according to the invention.
[0094] Examples:
[0095] The present invention is illustrated by the following eight examples, which do not limit the present invention.
[0096] Example 1 involves placing a polyurethane cellular foam in contact with an aqueous dopamine solution.
[0097] Example 2 concerns the functionalization of the cellular foam obtained in Example 1 with an aqueous luciferinamine solution.
[0098] Example 3 relates to the functionalization of the cellular foam obtained in Example 1 using a suspension of titanium dioxide TiO 2 nanoparticles in an aqueous medium.
[0099] Example 4 concerns the functionalization of the cellular foam obtained in step 1 with a suspension of ruthenium (Ru(0)) nanoparticles in an aqueous medium.
[0100] Example 5 relates to the photocatalysis of Acid Orange 7 using the functionalized cellular foam obtained in Example 3.
[0101] Example 6 relates to a styrene hydrogenation test using the functionalized cellular foam obtained in Example 4.
[0102] Example 7 involves the functionalization of polyurethane cellular foams modified by dopamine via Michael 1,4-addition of thiols or Schiff base reaction of amines (and / or via Michael 1,4-addition).
[0103] Example 8 involves incorporating into a one-step functionalization of a polyurethane cellular foam with an aqueous dopamine solution containing titanium dioxide TiO2 nanoparticles.
[0104] In these examples, certain abbreviations have been used:
[0105] PU: Polyurethane foam
[0106] PDA: Polydopamine
[0107] PU-PDA: Polyurethane foam containing an intermediate polydopamine phase on its surface.
[0108] Ru: ruthenium.
[0109] PU-PDA-Fluo: Polyurethane foam containing a middle polydopamine phase and an upper fluoresceinamine phase.
[0110] PU-PDA-Ru(0): Polyurethane foam containing an intermediate polydopamine phase and a catalytically active phase consisting of ruthenium nanoparticles.
[0111] PU-PDA-TiO2: Polyurethane foam containing an intermediate polydopamine phase and a catalytically active phase consisting of titanium dioxide nanoparticles.
[0112] at: ambient temperature
[0113] Example 1: Standardization for grafting polydopamine (PDA) on the surface of polyurethane (PU) foam to obtain PU-PDA foam Standard Procedure
[0114] In Example 1, a polyvalent matrix for a heterogeneous catalyst or a supported homogeneous catalyst is obtained by placing a polyurethane elastomer honeycomb foam in contact with a dopamine solution, which corresponds to the following reaction: Figure 1 :
[0115] reaction Figure 1 :Preparation of Catalyst Support
[0116]
[0117] In a stirred solution of 4-(2-aminoethyl)-1,2-benzenediol hydrochloride (CAS: 62-31-7, also known as dopamine hydrochloride) prepared by dissolving dopamine hydrochloride (2 mg / ml) in an aqueous solution (60 mL) of tris(hydroxymethyl)aminomethane (sometimes referred to as "trishydroxymethylaminomethane"; CAS 77-86-1) at a molar concentration of 10 mM, the pH was adjusted to 8.5 by dropwise addition of 1 M aqueous HCl solution, which was immersed in a 5% ethanol solution from the company. C31410Bulpren TM Polyurethane foam samples or from companies The 8FM2 measures 2 x 2 x 2 cm 3 and having a mass comprised between 200 mg and 250 mg. The reaction mixture is stirred at ambient temperature for 24 hours. The polymerization process of dopamine to polydopamine is characterized by a change in the color of the reaction medium to dark brown. The polyurethane foam grafted with polydopamine (PU-PDA) is then rinsed with ultrapure water (MiliQ) and then stirred for 10 min in 50 mL of MiliQ water. The washing procedure is repeated 5 times. The persistent light brown color on the foam surface is a characteristic of effective grafting of PDA. The obtained product is dried by a stream of compressed air and then dried overnight in a drying oven (60° C. to 70° C.).
[0118] Analysis of the foam surface obtained by x-ray photoelectron spectroscopy (XPS) confirmed that polydopamine was adsorbed onto the C31410Bulpren TM Polyurethane foam samples or from companies The surface of 8FM2 (cf. Figure 2a and Figure 2b The presence of PDA and its anti-washing property are confirmed by the significant increase in the O(1s) / C(1s) atomic ratio measured by XPS between the unmodified and modified elastomer foams. C31410Bulpren TM The presence of PDA on the surface of polyurethane foam samples (cf. Figure 3aand 3b ).
[0119] Example 2: Grafting of fluoresceinamine on the surface of polyurethane foam functionalized with polydopamine (PU-PDA) Standard procedure
[0120] In this example, the PU-PDA foam obtained in Example 1 is functionalized with an aqueous fluoresceinamine solution to form a fluorescent compound called PU-PDA-Fluo. The purpose of this example is in particular to show that it is possible to functionalize polydopamine by reaction with amine groups (by Schiff base reaction and / or Michael 1,4-addition), which makes it possible to consider the functionalization of PU-PDA with any molecule comprising amine groups, including metal complexes. This fluorescent compound in fact allows the functionalization of the polydopamine layer formed on the surface of the polyurethane foam to be easily visualized by using optical fluorescence microscopy techniques.
[0121] The PU-PDA foam prepared according to Example 1 was immersed in a stirred solution of 5-aminofluorescein (CAS: 3326-34-9, also known as luciferamine, isomer I), which was prepared by diluting 5-aminofluorescein (0.5 mg / mL) in an aqueous solution of 10 mM Tris·HCl (pH 8.5, 60 mL) prepared according to Example 1. The reaction mixture was stirred and heated at 60° C. for 3 hours and then stirred at ambient temperature for 16 hours. The PU-PDA foam grafted with luciferamine (PU-PDA-luciferamine) was then rinsed with ultrapure water (MiliQ) and then stirred in 50 mL of MiliQ water for 10 min. The washing procedure was repeated 3 times. The PU-PDA-Fluo thus obtained was dried by a stream of compressed air and then kept at ambient temperature. Fluorescence microscopic analysis (excitation at 365 nm) confirmed the presence of luciferamine on the surface of the PU-PDA-Fluo foam; the layer was continuous and homogeneous. When PU-PDA foams were modified by luciferinamine, the fluorescence intensity (using Software) is twice as high relative to the same unmodified foam.
[0122] In addition, the presence of fluoresceinamine on the surface of PU-PDA-Fluo foam was also confirmed by XPS. The 34% decrease in the O(1s) / C(1s) atomic ratio and the 14% decrease in the N(1s) / C(1s) ratio between PU-PDA foam and PU-PDA-Fluo foam confirmed the grafting of amine derivatives.
[0123] Use Company Similar experiments were performed on 8FM2 polyurethane foam with similar results.
[0124] Example 3: Grafting TiO2 nanoparticles on the surface of polyurethane foam functionalized with polydopamine (PU-PDA) Standard procedure for particles
[0125] In this example, the PU-PDA foam obtained in Example 1 was functionalized with a suspension of titanium dioxide metal nanoparticles in an aqueous medium to form a catalyst, referred to as PU-PDA-TiO2.
[0126] 1 gram of commercially available TiO2 nanopowder (anatase type and having a particle size of about 15 nm) was added to a 10 mM Tris·HCl aqueous solution (pH 8.5, 50 mL) prepared according to Example 1. After having been stirred overnight at 1,000 rpm using a magnetic stirrer, the TiO2 suspension was ultrasonically treated in a water bath (25°C) for 30 min to obtain a suspension of well-dispersed TiO2 nanoparticles. The PU-PDA foam prepared according to Example 1 was immersed in this suspension of TiO2 nanoparticles, and the reaction mixture was then stirred at about 1,000 rpm and heated at 40°C for 3 hours. The PU-PDA foam grafted with TiO2 nanoparticles (PU-PDA-TiO2) was then rinsed with MiliQ ultrapure water and then stirred in 50 mL of MiliQ water for 10 min. The washing procedure was repeated 5 times. The obtained product (PU-PDA-TiO2) was dried by a stream of compressed air and then dried in a drying oven (60 to 70°C) overnight.
[0127] Photoelectron spectroscopy analysis (% Ti 2p / %C 1s =0.09871) and scanning electron microscopy (SEM) analysis confirmed the presence of TiO2 nanoparticles on the surface of PU-PDA foam (cf. Figure 3c , Figure 6a , Figure 6b ).
[0128] Example 4: Grafting of Ru(0) nanoparticles on the surface of polyurethane foam functionalized with polydopamine (PU-PDA) Standard procedure for particles
[0129] In this example, the PU-PDA foam obtained in Example 1 was functionalized with a suspension of metallic ruthenium nanoparticles in an aqueous medium to form a catalyst referred to as PU-PDA-Ru(0). The reaction scheme for preparing this foam is shown below:
[0130] Reaction diagram 2: Preparation of ruthenium nanoparticle-based catalysts
[0131]
[0132] Added dropwise to an aqueous solution (50 mL) of RuCl3·3H2O (26.1 mg; 0.1 mM) was a freshly prepared 0.1 M aqueous solution of NaBh4 (1.8 mL) under vigorous stirring and at ambient temperature. The reduction process occurs rapidly and is characterized by a gradual change of color; from dark brown to light brown, then greenish brown, and finally back to dark brown. The addition of NaBH4 is complete when the reaction medium has turned dark brown again (pH < 4.9). The colloidal solution is then stirred overnight at ambient temperature to obtain a well-dispersed suspension of ruthenium (0) nanoparticles, wherein the particle size is comprised between 1 nm and 2 nm.
[0133] The PU-PDA foam prepared according to Example 1 was immersed in this suspension of ruthenium nanoparticles, and the reaction medium was then stirred at ambient temperature for 24 hours. The PU-PDA foam grafted with ruthenium (0) nanoparticles (PU-PDA-Ru(0)) was then rinsed with MiliQ water and then stirred in 50 mL of MiliQ water for 10 min. The washing procedure was repeated 5 times. The PU-PDA-Ru(0) was dried by a stream of compressed air and then dried in a drying oven (60° C. to 70° C.) overnight.
[0134] Example 5: Photocatalysis of Acid Orange 7 using PU-PDA-TiO2 as catalyst
[0135] In this example, the photocatalytic test of Acid Orange 7 (AO7) was carried out using the PU-PDA-TiO2 honeycomb foam obtained in Example 3. The reaction diagram is shown below:
[0136] Reaction Scheme 3: Photocatalysis of Acid Orange AO7
[0137]
[0138] Four samples of PU-PDA-TiO2 foam (previously prepared according to Example 3 and measuring 0.5×2×2 cm 3 ) was immersed in a 100 mL beaker at 2.7·10 -5 The mixture was stirred in an aqueous solution (50 mL) of 4-(2-hydroxy-1-naphthylazo)benzenesulfonic acid sodium salt (CAS: 633-96-5, commonly known as Acid Orange 7 or AO7) at a concentration of 4 M (pH ~ 5.4). The solution was stirred at 250 rpm for 30 min in the dark to equilibrium and then irradiated by 3 bulbs (1 visible bulb at 100 W placed above and 2 UVA bulbs (λ max =365 nm), placed on the side). The reaction medium was stirred for 22 hours. The catalytic conversion of AO7 was characterized by a color change of the solution and monitored by UV-visible spectrophotometry (cf. UV spectrum - Figure 4). This catalytic conversion was complete in 22 hours and the foam could be reused at least once after washing with ultrapure water (MiliQ) without loss of activity.
[0139] Example 6: Styrene hydrogenation using PU-PDA-Ru(0) as catalyst
[0140] In this example, the hydrogenation of styrene 1 to ethylbenzene 2 was carried out using the PU-PDA-Ru(0) honeycomb foam obtained in Example 4. The reaction diagram is shown below:
[0141] reaction Figure 4 :Styrene hydrogenation
[0142]
[0143] According to the state of the art, this reaction may form ethylcyclohexane 3 as a by-product.
[0144] The hydrogenation of styrene 1 was carried out in a glass 4-neck reactor (250 mL) equipped with a condenser. PU-PDA-Ru(0) was fixed at the end of a mechanical stirrer in a glass cage with holes. The catalyst was immersed in a solution (0.23 mL; 0.02 M) of styrene in ethanol (100 mL). Under mechanical stirring (about 450 rpm), the reaction medium was heated at 70° C. and hydrogen was continuously boiled in the solution at a flow rate of 60 ml / min. After 6 hours and 22 hours of reaction, 0.5 mL of the reaction medium was withdrawn and analyzed by gas chromatography to determine the conversion. After 6 hours of reaction, 4% ethylbenzene 2 was obtained; after 22 hours of reaction, 7% ethylbenzene 2 was obtained. The amount of ethylcyclohexane 3 formed was negligible, which highlights the selectivity of the reaction with this catalytic system.
[0145] This example also shows that if dopamine is used as compound (b) in the process according to the invention, it is possible to eliminate the step for reducing the active phase (Ru). In the case of systems according to the state of the art in which the catalyst is deposited on a ceramic, carbon or metal substrate, this step is required or even necessary.
[0146] Example 7: Functionalization of PU-PDA foams by grafting thiols or amines
[0147] HS-(CH2) 2- COOH grafted on polydopamine (PU-PDA) via Michael 1,4-addition modification of thiol functional groups on the aromatic ring of PDA C31410Bulpren TM Polyurethane foam. For this purpose, HS-(CH2) 2-COOH was used at a rate of 0.5 mg / ml in an aqueous solution of NaOH (0.1 M) at ambient temperature. The presence of thiols on the thus modified PU-PDA foam was confirmed by XPS. The presence of thiols was confirmed by a significant increase in the S(2p) / C(1s) atomic ratio measured by XPS between the unmodified PU-PDA foam and the modified PU-PDA foam. The same experiment was performed on 8FM2 polyurethane foam, with similar results.
[0148] In another experiment, NH2-(CH2)6-NH2 was grafted onto polydopamine (PU-PDA) modified via Schiff base reaction (and / or Michael 1,4 reaction). C31410Bulpren TM On polyurethane foam. For this purpose, NH2-(CH2)6-NH2 was used under the following conditions: at a rate of 0.5 mg / ml in an aqueous tris(hydroxymethyl)aminomethane solution (15 mM) at a pH of 8.6 for three hours at 60°C, followed by 16 hours at . The presence of amines on the PU-PDA foam thus modified was demonstrated by XPS. The presence of amines was demonstrated by a 14% decrease in the O(1s) / C(1s) atomic ratio and a 63% increase in the N(1s) / C(1s) atomic ratio measured by XPS between the unmodified PU-PDA foam and the modified PU PA foam. Using the company Similar experiments were performed on 8FM2 polyurethane foam with similar results.
[0149] Example 8: Obtaining PU-PDA foam grafted with TiO2 nanoparticles in a single step (referred to as PDU-PDA- TiO2)
[0150] In this example, the PU-PDA-TiO2 catalyst was obtained in a single step by placing a polyurethane elastomer honeycomb foam in contact with a suspension of titanium trioxide metal nanoparticles in an aqueous dopamine solution.
[0151] Reaction Scheme 5: Preparation of PU-PDA-TiO2 catalyst in a single step
[0152]
[0153] 2% (w / v) of commercially available TiO2 nanopowder (anatase type and having a particle size of about 30 nm) was added to a 10 mM aqueous solution of Tris·HCl (pH 8.5) prepared according to Example 1. After stirring at 1,000 rpm for 12 hours using a magnetic stirrer, 2 mg / ml of 4-(2-aminoethyl)-1,2-benzenediol hydrochloride (CAS: 62-31-7, also known as dopamine hydrochloride) was added. In this TiO2 nanoparticle suspension, a polyurethane foam sample similar to that used in Example 1 was immersed, and the reaction mixture was then stirred at about 1,000 rpm and heated at 40°C for 24 hours. The PU-PDA foam grafted with TiO2 nanoparticles (PU-PDA-TiO2) was then rinsed with MiliQ ultrapure water and then stirred in 50 mL of MiliQ water for 10 min. The washing procedure was repeated 5 times. The obtained product (PU-PDA-TiO2) was dried by a stream of compressed air and then in a drying oven (60 to 70°C) for at least 12 hours.
Claims
1. A method for modifying an elastomeric cellular foam having significant porosity, comprising the following steps: a) supplying a porous elastomeric cellular foam (a) having significant porosity; b) placing the elastomeric honeycomb foam (a) in contact with a compound (b) comprising at least one catechol unit, thereby obtaining a catalyst substrate comprising the elastomeric honeycomb foam (a), the elastomeric honeycomb foam (a) having a mesophase formed by the compound comprising at least one catechol unit on its surface, The average equivalent diameter of the openings of the pores of the elastomeric honeycomb foam (a) is between 100 μm and 5000 μm.
2. The method according to claim 1, characterized in that The elastomeric honeycomb foam (a) is made of polyurethane.
3. The method according to claim 1 or 2, characterized in that The compound comprising at least one catechol unit is a catecholamine.
4. The method according to claim 1 or 2, characterized in that The compound comprising at least one catechol unit is a catechol monoamine.
5. The method according to claim 1 or 2, characterized in that Said step for placing said elastomeric cellular foam (a) and said compound (b) in contact is carried out according to one of the following techniques: i) immersing the elastomeric honeycomb foam (a) in an aqueous solution of a compound (b), ii) impregnating the elastomer honeycomb foam (a) with an aqueous solution of the compound (b), iii) spraying the aqueous solution of compound (b) partially or completely on the elastomeric cellular foam (a).
6. The method according to claim 3, characterized in that The compound (b) selected from catecholamines is 4-(2-aminoethyl)benzene-1,2-diol or a derivative thereof.
7. The method according to claim 3, further comprising a step c) for functionalizing the elastomeric cellular foam (a) by depositing at least one phase of catalytically active material or a precursor of a catalytically active phase (c), the phase of at least one catalytically active material or a precursor of a catalytically active phase (c) being selected from the group consisting of: a metal complex comprising at least one group capable of forming a covalent bond with the coating of said mesophase formed by compound (b); a metal complex comprising at least one group capable of forming a covalent bond with a catechol or indole structural unit resulting from cyclization of the alkylamine arm of the catecholamine during step (b); organic molecules capable of catalyzing the reaction, called organocatalysts, comprising at least one group capable of forming a covalent bond with the coating of said mesophase formed by compound (b); Metal nanoparticles.
8. The method according to claim 7, characterized in that The at least one group capable of forming a covalent bond with the coating of the mesophase formed by compound (b) is selected from the group consisting of trialkoxysilyl groups, amine groups or thiol groups.
9. The method according to claim 7 or 8, characterized in that The metal complex comprising at least one group capable of forming a covalent bond with the coating layer of the mesophase formed by compound (b) is a coordination compound of a transition metal or an organometallic molecule.
10. The method according to claim 7 or 8, characterized in that The metal nanoparticles are selected from metal nanoparticles of Ag, Fe, Co, Ni, Ru, Rh, Pd, Ir, Pt, Au, Ce or those of mixed oxides associated with these elements, or from TiO2, ZnO, WO3, SnO2 or any possible combination of these nanoparticles.
11. The method according to claim 7 or 8, characterized in that The metal nanoparticles have an average particle size between 0.5 nm and 100 nm.
12. The method according to claim 7 or 8, characterized in that Said step c) for functionalizing said elastomeric cellular foam (a) is carried out by depositing said active phase using at least one of the following techniques: Dip, aerosol or droplet; Chemical vapor deposition; Capillary impregnation.
13. The method according to claim 7 or 8, characterized in that Said step c) is carried out after or simultaneously with the deposition of compound (b).
14. The method according to claim 7 or 8, characterized in that Said step c) is carried out at a temperature between 5°C and 80°C.
15. A functionalized elastomeric cellular foam having a pronounced porosity obtainable using a method according to any one of claims 7 to 14.
16. Use of an elastomeric cellular foam with pronounced porosity obtainable by the method according to any one of claims 1 to 6 as a catalyst substrate.
17. Use of a functionalized elastomeric cellular foam having significant porosity obtainable using the method according to any one of claims 8 to 14 as a catalyst.
Citation Information
Patent Citations
Three-dimensional foam photocatalysts structured with carbon or carbonated material
CN102215879A
Photocatalytic inorganic nanoparticle / polydopamine / polymer self-cleaning composite film and preparation method thereof
CN103566776A
Method for surface modification of hydrophobic polymer microporous membrane
CN103613780A
Absorbent and / or filter materials comprising open cell foams coated with photocatalytic titanium dioxide, and methods of making and using the same
US20080178738A1
